Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study

The effects of sorafenib for Chinese patients with metastatic renal cell cancer (mRCC) were evaluated to figure out the relationship between clinical variables and prognosis. The data were analyzed retrospectively from six comprehensive cancer centers in Northeast China. All cases were diagnosed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Fang, Han, Tao, Liu, Zhaozhe, Song, Xishuang, Zhang, Qifu, Kong, Xiangbo, Li, Changfu, Li, Zhenhua, Li, Chengge, Qu, Shuxian, Zheng, Zhendong, Piao, Ying, Han, Yaling, Xie, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489821/
https://www.ncbi.nlm.nih.gov/pubmed/26170693
http://dx.doi.org/10.2147/OTT.S84994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489821/
https://www.ncbi.nlm.nih.gov/pubmed/26170693
http://dx.doi.org/10.2147/OTT.S84994

Ejemplares similares